Amminger, G P <br/><br/>
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.  [electronic resource] 

 -  Translational psychiatry  Jan 2015 
 - e495 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2158-3188 
<br/><br/><label>Standard No.: </label>10.1038/tp.2014.134  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Arachidonic Acid--metabolism<br/>Docosahexaenoic Acids--metabolism<br/>Double-Blind Method<br/>Eicosapentaenoic Acid--metabolism<br/>Erythrocyte Membrane--metabolism<br/>Fatty Acids--metabolism<br/>Fatty Acids, Omega-3--therapeutic use<br/>Fatty Acids, Unsaturated--metabolism<br/>Female<br/>Humans<br/>Linear Models<br/>Linoleic Acid--metabolism<br/>Male<br/>Multivariate Analysis<br/>Psychotic Disorders--drug therapy<br/>Risk<br/>Treatment Outcome<br/>Vitamin E--therapeutic use<br/>Vitamins--therapeutic use<br/>Young Adult<br/>alpha-Linolenic Acid--metabolism